{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:52:04Z","timestamp":1773373924206,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:00:00Z","timestamp":1218153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:bold>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003In parts of South\u2010East Asia, Tincture of Opium (TOP) is a culturally acceptable alternative to methadone in the treatment of opioid withdrawal.<\/jats:p><jats:p>\u2022\u2003We have previously shown that TOP has a therapeutic effect when administered to opioid\u2010dependent patients in Northern Thailand.<\/jats:p><jats:p>\u2022\u2003However, before TOP could be used clinically, an evaluation of the dosing regimen had to be undertaken.<\/jats:p><jats:p> <jats:bold>WHAT THIS STUDY ADDS<\/jats:bold> <\/jats:p><jats:p>\u2022\u2003This study extends the previous study by evaluating the clinical effectiveness of a dosing regimen in which the TOP dose was adjusted according to prior self\u2010reported opium use.<\/jats:p><jats:p>\u2022\u2003Adequate suppression of withdrawal can be achieved, with minimal side\u2010effects, in opioid\u2010dependent individuals receiving flexible dosing of TOP.<\/jats:p><jats:p>\u2022\u2003This study provides preliminary evidence for the effectiveness of TOP in the management of opioid withdrawal.<\/jats:p><\/jats:sec><jats:sec><jats:title>AIMS<\/jats:title><jats:p>The aim was to evaluate the clinical effectiveness, pharmacodynamics and pharmacokinetics of a range of Tincture of Opium (TOP) doses in the management of opioid withdrawal.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Forty\u2010five opium\u2010dependent Thai subjects were allocated to three dosing groups (6.66, 13.3 and 20\u2003mg morphine equivalents, twice daily) depending on their self\u2010reported prior opium use. On day 5 of dosing subjects underwent an interdosing interval study where blood, withdrawal scores, heart rate and blood pressure (BP) were collected at 0, 1, 3 and 8\u2003h. Plasma morphine concentrations were quantified by high\u2010performance liquid chromatography, and plasma morphine\u20103\u2010glucuronide (M3G) and morphine\u20106\u2010glucuronide (M6G) concentrations by LCMS.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Thirty\u2010two subjects completed the study. Withdrawal scores were low for all subjects (range 9\u201323% of maximum response). There were dose\u2010dependent changes in both systolic and diastolic BP (<jats:italic>P<\/jats:italic>\u2003=\u20030.021 and <jats:italic>P<\/jats:italic>\u2003=\u20030.01, respectively), but these were not considered clinically significant. There were no effects of dose on respiratory rate. Plasma morphine concentrations changed significantly across the interdosing interval (<jats:italic>P<\/jats:italic>\u2003=\u20030.0001), rising to a maximum at 1\u2003h after dosing. Plasma morphine concentrations also differed according to dose (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). The mean ratios of the morphine glucuronides were found to be: M3G\/M6G\u2003=\u20037.7, M3G\/morphine\u2003=\u200335.6 and M6G\/morphine\u2003=\u20034.9, values comparable to those previously reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>The management of opioid withdrawal can be achieved, with minimal adverse effects, by using flexible dosing of TOP.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2125.2008.03277.x","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T11:06:15Z","timestamp":1218193575000},"page":"640-647","source":"Crossref","is-referenced-by-count":14,"title":["Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics"],"prefix":"10.1111","volume":"66","author":[{"given":"Andrew A.","family":"Somogyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza M.","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroon","family":"Jittiwutikarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978232175"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/1355621961000124736"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05356-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(97)90003-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: impact of methadone treatment","volume":"82","author":"Gr\u00f8ndbladh L","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06683.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9345157.x"},{"key":"e_1_2_6_9_2","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in\u2010 and out\u2010of\u2010treatment: an 18\u2003month prospective follow\u2010up","volume":"6","author":"Metzger DS","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02209.x"},{"key":"e_1_2_6_11_2","unstructured":"WHO\/UNODC\/UNAIDS.Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention: position paper.2004. Available athttp:\/\/www.who.int\/substance_abuse\/publications\/en\/PositionPaper_English.pdf(last accessed 27 March 2008)."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(94)90008-6"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey","volume":"26","author":"Sarka S","year":"2006","journal-title":"J. Perinatol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.123099"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.07.001","article-title":"Therapy of neonatal abstinence syndrome with tincture of opium or morphine drops","volume":"77","author":"Langenfield S","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1531-x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)90090-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00306-2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(91)80410-E"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb02148.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3959(82)90014-8","article-title":"Plasma morphine concentrations during chronic oral administration in patients with cancer pain","volume":"13","author":"Nemann PB","year":"1982","journal-title":"Pain"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00020-1"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324050-00005"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00268-J"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199506000-00013"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2008.03277.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2008.03277.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:13:15Z","timestamp":1697454795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2008.03277.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,28]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2125.2008.03277.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03277.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,28]]}}}